Inhibitory effects of novel 3(2H)pyridazinone-triazole derivatives against acetylcholinesterase enzyme

ArticleAçık Erişim

Özet

Alzheimer's disease is a neurological disease characterized by the destruction of brain cells. In this disease, which causes a decrease in thought, memory and behavioral functions, the symptoms appear gradually with age. In this study, inhibition of acetylcholinesterase enzyme which is an important target in accordance with the cholinergic hypothesis, was studied. New 3(2H)pyridazinone-triazole derivatives were synthesized, confirmed by1H-NMR,13C-NMR, HRMS analysis and their IC50 and Ki values were studied. The inhibition constants (Ki) of the compounds against the AChE enzyme ranged from 2.35 ± 0.18 to 5.15 ± 0.46 µM. The compound with the best inhibitory properties was compound 6d with a Ki value of 2.35 ± 0.18 µM. In addition, to support the experimental data, molecular docking studies were carried out with 6b, 6d, 6e and 6f compounds with AChE crystal structure (PDB ID:4M0E). © 2022 Marmara University Press.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12627Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.29228/jrp.239Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBozbey, İrem
dc.contributor.authorÖnel, Gülce Taşkor
dc.contributor.authorTürkmenoğlu, Burçin
dc.contributor.authorGürsoy, Şule
dc.contributor.authorDilek, Esra
dc.contributor.authorErgün, Muhammed
dc.contributor.authorÖzçelik, Azime Berna
dc.contributor.authorUysal, Mehtap
dc.date.accessioned2026-10-18T20:27:30.502010463Z
dc.date.available2026-10-18T20:27:30.502010463Z
dc.date.issued2022
dc.description.abstractAlzheimer's disease is a neurological disease characterized by the destruction of brain cells. In this disease, which causes a decrease in thought, memory and behavioral functions, the symptoms appear gradually with age. In this study, inhibition of acetylcholinesterase enzyme which is an important target in accordance with the cholinergic hypothesis, was studied. New 3(2H)pyridazinone-triazole derivatives were synthesized, confirmed by1H-NMR,13C-NMR, HRMS analysis and their IC50 and Ki values were studied. The inhibition constants (Ki) of the compounds against the AChE enzyme ranged from 2.35 ± 0.18 to 5.15 ± 0.46 µM. The compound with the best inhibitory properties was compound 6d with a Ki value of 2.35 ± 0.18 µM. In addition, to support the experimental data, molecular docking studies were carried out with 6b, 6d, 6e and 6f compounds with AChE crystal structure (PDB ID:4M0E). © 2022 Marmara University Press.
dc.description.sponsorshipFunding text 1: Acknowledgements: We thank Erzincan Binali Yıldırım University (Project Number: TSA-2020-664) for their financial support. The authors would like to thank Erzincan Binali Yıldırım University, Basic Sciences Application and Research Center (EBYU-EUTAM) for the Schrödinger Maestro 2021-2 program.; Funding text 2: We thank Erzincan Binali Yıldırım University (Project Number: TSA-2020-664) for their financial support. The authors would like to thank Erzincan Binali Yıldırım University, Basic Sciences Application and Research Center (EBYU-EUTAM) for the Schrödinger Maestro 2021-2 program.
dc.identifier.doi10.29228/jrp.239
dc.identifier.eissn2630-6344
dc.identifier.endpage1471
dc.identifier.issn2630-6344
dc.identifier.issue5
dc.identifier.scopus2-s2.0-85137920793
dc.identifier.startpage1461
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12627
dc.identifier.volume26
dc.identifier.wosWOS:000929825400035
dc.language.isoen
dc.publisherMarmara University
dc.relation.ispartofJournal of Research in Pharmacy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcetylcholinesterase
dc.subjectalzheimer’s disease
dc.subjectmolecular docking
dc.subjectpyridazinone
dc.subjecttriazole
dc.subject2 [[4 (3 bromophenyl) 5 thioxo 4,5 dihydro 1h 1,2,4 triazol 3 yl]methyl] 6 [4 (4 chlorophenyl)piperazin 1 yl]pyridazin 3(2h) one
dc.subject2 [[4 (4 bromophenyl) 5 thioxo 4,5 dihydro 1h 1,2,4 triazol 3 yl]methyl] 6 [4 (4 chlorophenyl)piperazin 1 yl]pyridazin 3(2h) one
dc.subject3(2h)pyridazinone triazole
dc.subject6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [(4 phenyl 6 thioxo 4,5 dihydro 1h 1,2,4 triazol 3 yl)methyl]pyridazin] 3(2h) one
dc.subject6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [[4 (2 methoxyphenyl)-5-thioxo-4,5-dihydro 1h 1,2,4 triazol 3 yl]methyl]pyridazin 3(2h) one
dc.subject6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [[4 (3 methoxyphenyl)-5-thioxo-4,5-dihydro 1h 1,2,4 triazol 3 yl]methyl]pyridazin 3(2h) one
dc.subject6 [4 (4 chlorophenyl)piperazin 1 yl] 2 [[5 thioxo 4 [4 (trifluoromethoxy)phenyl] 4,5 dihydro 1h 1,2,4 triazol 3 yl]methyl]pyridazin 3(2h) one
dc.subjectcholinesterase inhibitor
dc.subjecttacrine
dc.subjecttriazole derivative
dc.subjectunclassified drug
dc.subjectArticle
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcrystal structure
dc.subjectenzyme inhibition
dc.subjectIC50
dc.subjectinhibition constant
dc.subjectmass spectrometry
dc.subjectproton nuclear magnetic resonance
dc.titleInhibitory effects of novel 3(2H)pyridazinone-triazole derivatives against acetylcholinesterase enzyme
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus4
rdl.citation.trdizin0
rdl.citation.wos2
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentSİVAS CUMHURİYET ÜNİVERSİTESİ
rdl.departmentGAZİ ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)